Bone morphogenetic protein receptors and signal transduction

Journal of Biochemistry

Volumn 147, Issue 1, 2010, Pages 35-51

  Miyazono, Kohei ^a   Kamiya, Yuto ^a   Morikawa, Masato ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

BMP; GDF; Serine threonine kinase; Smad; TGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; PROTEASOME; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN;

BRACHYDACTYLY; ENZYME ACTIVATION; GENE TARGETING; HUMAN; LIGAND BINDING; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN FUNCTION; PULMONARY HYPERTENSION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; HUMANS; LIGANDS; PYRAZOLES; PYRIMIDINES; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 75649127963     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvp148     Document Type: Review

References (137)

1. Katagiri, T., Suda, T., and Miyazono, K. (2008) The bone morphogenetic proteins in The TGF-β Family (Derynck R. and Miyazono K., eds.), pp. 121-149, Cold Spring Harbor Laboratory Press, New York
2. Derynck, R. and Miyazono, K. (2008) TGF-β and the TGF-β family in The TGF-β Family (Derynck R. and Miyazono K., eds.), pp. 29-43, Cold Spring Harbor Laboratory Press, New York
3. Kawabata, M., Imamura, T., and Miyazono, K. (1998) Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 9, 49-61 (Pubitemid 28280536)
4. Cheng, H., Jiang, W., Phillips, F.M., Haydon, R.C., Peng, Y., Zhou, L., Luu, H.H., An, N., Breyer, B., Vanichakarn, P., Szatkowski, J.P., Park, J.Y., and He, T.C. (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J. Bone Joint Surg. Am. 85-A, 1544-1552
5. Miyazono, K., Maeda, S., and Imamura, T. (2005) BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16, 251-263
6. Patterson, G.I. and Padgett, R.W. (2008) TGF-β family signaling in the nematode C. elegans in The TGF-β Family (Derynck R. and Miyazono K., eds.), pp. 527-546, Cold Spring Harbor Laboratory Press, New York
7. Pyrowolakis, G., Hartmann, B., and Affolter, M. (2008) TGF-β family signaling in Drosophila in The TGF-β Family (Derynck R. and Miyazono K., eds.), pp. 493-526, Cold Spring Harbor Laboratory Press, New York
8. Chang, C. (2008) Agonists and antagonists of the TGF-β family ligands in The TGF-β Family (Derynck R. and Miyazono K., eds.), pp. 203-258, Cold Spring Harbor Laboratory Press, New York
9. Heldin, C.-H., Miyazono, K., and ten Dijke, P. (1997) TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471
10. Derynck, R. and Zhang, Y.E. (2003) Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425, 577-584
11. Rosenzweig, B.L., Imamura, T., Okadome, T., Cox, G.N., Yamashita, H., ten Dijke, P., Heldin, C.- H., and Miyazono, K. (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl Acad. Sci. USA 92, 7632-7636
12. Yu, P.B., Beppu, H., Kawai, N., Li, E., and Bloch, K.D. (2005) Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. J. Biol. Chem. 280, 24443-24450
13. ten Dijke, P., Yamashita, H., Sampath, T.K., Reddi, A.H., Estevez, M., Riddle, D.L., Ichijo, H., Heldin, C.-H., and Miyazono, K. (1994) Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269, 16985-16988
14. Nishitoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., Enomoto, S., and Miyazono, K. (1996) Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J. Biol. Chem. 271, 21345-21352 (Pubitemid 26292996)
15. Brown, M.A., Zhao, Q., Baker, K.A., Naik, C., Chen, C., Pukac, L., Singh, M., Tsareva, T., Parice, Y., Mahoney, A., Roschke, V., Sanyal, I., and Choe, S. (2005) Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J. Biol. Chem. 280, 25111-25118
16. David, L., Mallet, C., Mazerbourg, S., Feige, J.J., and Bailly, S. (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109, 1953-1961
17. Scharpfenecker, M., van Dinther, M., Liu, Z., van Bezooijen, R.L., Zhao, Q., Pukac, L., Löwik, C.W., and ten Dijke, P. (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J. Cell Sci. 120, 964-972
18. Oh, S.P., Seki, T., Goss, K.A., Imamura, T., Yi, Y., Donahoe, P.K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., and Li, E. (2000) Activin receptor-like kinase1 modulates transforming growth factor-b1 signaling in the regulation of angiogenesis. Proc. Natl Acad. Sci. USA 97, 2626-2631
19. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S., and ten Dijke, P. (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFb/ ALK5 signaling. Mol. Cell 12, 817-828
20. Samad, T.A., Rebbapragada, A., Bell, E., Zhang, Y., Sidis, Y., Jeong, S.J., Campagna, J.A., Perusini, S., Fabrizio, D.A., Schneyer, A.L., Lin, H.Y., Brivanlou, A.H., Attisano, L., and Woolf, C.J. (2005) DRAGON, a bone morphogenetic protein co-receptor. J. Biol. Chem. 280, 14122-14129
21. Babitt, J. L., Zhang, Y., Samad, T.A., Xia, Y., Tang, J., Campagna, J.A., Schneyer, A.L., Woolf, C. J., and Lin, H.Y. (2005) Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J. Biol. Chem. 280, 29820-29827
22. Babitt, J.L., Huang, F.W., Wrighting, D.M., Xia, Y., Sidis, Y., Samad, T.A., Campagna, J.A., Chung, R.T., Schneyer, A.L., Woolf, C.J., Andrews, N.C., and Lin, H.Y. (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38, 531-539
23. Xia, Y., Yu, P.B., Sidis, Y., Beppu, H., Bloch, K.D., Schneyer, A.L., and Lin, H.Y. (2007) Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4. J. Biol. Chem. 282, 18129-18140
24. Barbara, N.P., Wrana, J.L., and Letarte, M. (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-b superfamily. J Biol. Chem. 274, 584-594
25. Scherner, O., Meurer, S.K., Tihaa, L., Gressner, A.M., and Weiskirchen, R. (2007) Endoglin differentially modulates antagonistic transforming growth factor-b1 and BMP-7 signaling. J. Biol. Chem. 282, 13934-13943
26. McAllister, K.A., Grogg, K.M., Johnson, D.W., Gallione, C.J., Baldwin, M.A., Jackson, C.E., Helmbold, E.A., Markel, D.S., McKinnon, W.C., Murrell, J., McCormick, M.K., Pericak-Vance, M.A., Heutink, P., Oostra, B.A., Haitjema, T., Westerman, C.J.J., Porteous, M.E., Guttmacher, A.E., Letarte, M., and Marchuk, D.A. (1994) Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8, 345-351
27. Johnson, D.W., Berg, J.N., Baldwin, M.A., Gallione, C.J., Marondel, I., Yoon, S.J., Stenzel, T.T., Speer, M., Pericak-Vance, M.A., Diamond, A., Guttmacher, A.E., Jackson, C.E., Attisano, L., Kucherlapati, R., Porteous, M.E., and Marchuk, D.A. (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 13, 189-195
28. Kirsch, T., Sebald, W., and Dreyer, M.K. (2000) Crystal structure of the BMP-2-BRIA ectodomain complex. Nat. Struct. Biol. 7, 492-496
29. Greenwald, J., Groppe, J., Gray, P., Wiater, E., Kwiatkowski, W., Vale, W., and Choe, S. (2003) The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 11, 605-617
30. Allendorph, G.P., Vale, W.W., and Choe, S. (2006) Structure of the ternary signaling complex of a TGF-β superfamily member. Proc. Natl Acad. Sci. USA 103, 7643-7648
31. Kirsch, T., Nickel, J., and Sebald, W. (2000) BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J. 19, 3314-3324
32. Greenwald, J., Fischer, W.H., Vale, W.W., and Choe, S. (1999) Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase. Nat. Struct. Biol. 6, 18-22
33. Huse, M., Chen, Y.G., Massagué , J., and Kuriyan, J. (1999) Crystal structure of the cytoplasmic domain of the type I TGFb receptor in complex with FKBP12. Cell 96, 425-436
34. Kang, J.S., Liu, C., and Derynck, R. (2009) New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol. 19, 385-394
35. Onichtchouk, D., Chen, Y.G., Dosch, R., Gawantka, V., Delius, H., Massagué , J., and Niehrs, C. (1999) Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature 401, 480-485 (Pubitemid 29470206)
36. Sekiya, T., Oda, T., Matsuura, K., and Akiyama, T. (2004) Transcriptional regulation of the TGF-β pseudoreceptor BAMBI by TGF-β signaling. Biochem. Biophys. Res. Commun. 320, 680-684
37. Grotewold, L., Plum, M., Dildrop, R., Peters, T., and Rüther, U. (2001) Bambi is coexpressed with Bmp-4 during mouse embryogenesis. Mech. Dev. 100, 327-330
38. Jin, W., Yun, C., Kim, H.S., and Kim, S.J. (2007) TrkC binds to the bone morphogenetic protein type II receptor to suppress bone morphogenetic protein signaling. Cancer Res. 67, 9869-9877 (Pubitemid 47621235)
39. Sammar, M., Stricker, S., Schwabe, G.C., Sieber, C., Hartung, A., Hanke, M., Oishi, I., Pohl, J., Minami, Y., Sebald, W., Mundlos, S., and Knaus, P. (2004) Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2. Genes Cells 9, 1227-1238
40. Schwappacher, R., Weiske, J., Heining, E., Ezerski, V., Marom, B., Henis, Y.I., Huber, O., and Knaus, P. (2009) Novel crosstalk to BMP signalling: cGMP-dependent kinase I modulates BMP receptor and Smad activity. EMBO J. 28, 1537-1550
41. Mishina, Y., Suzuki, A., Ueno, N., and Behringer, R.R. (1995) Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev. 9, 3027-3037 (Pubitemid 26018138)
42. Beppu, H., Kawabata, M., Hamamoto, T., Chytil, A., Minowa, O., Noda, T., and Miyazono, K. (2000) BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev. Biol. 221, 249-258
43. Gu, Z., Reynolds, E.M., Song, J., Lei, H., Feijen, A., Yu, L., He, W., MacLaughlin, D.T., van den Eijndenvan Raaij, J., Donahoe, P.K., and Li, E. (1999) The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development 126, 2551-2561
44. Matzuk, M.M., Kumar, T.R., and Bradley, A. (1995) Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374, 356-360
45. Oh, S.P. and Li, E. (1997) The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev. 11, 1812-1826
46. Lane, K.B., Machado, R.D., Pauciulo, M.W., Thomson, J.R., Philips, J.A. III, Loyd, J.E., Nichols, W.C., and Trembath, R.C. (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nat. Genet. 26, 81-84
47. Deng, Z., Morse, J.H., Slager, S.L., Cuervo, N., Moore, K.J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S.G., Barst, R.J., Hodge, S.E., and Knowles, J.A. (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am. J. Hum. Genet. 67, 737-744
48. Fujiwara, M., Yagi, H., Matsuoka, R., Akimoto, K., Furutani, M., Imamura, S., Uehara, R., Nakayama, T., Takao, A., Nakazawa, M., and Saji, T. (2008) Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension. Circ. J. 72, 127-133
49. Hong, K.H, Lee, Y.J., Lee, E, Park, S.O., Han, C., Beppu, H., Li, E., Raizada, M.K., Bloch, K.D., and Oh, S.P. (2008) Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Circulation 118, 722-730
50. West, J., Harral, J., Lane, K., Deng, Y., Ickes, B., Crona, D., Albu, S., Stewart, D., and Fagan, K. (2008) Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions. Am. J. Physiol. Lung Cell Mol. Physiol. 295, L744-755
51. Song, Y., Coleman, L., Shi, J., Beppu, H., Sato, K., Walsh, K., Loscalzo, J., and Zhang, Y.Y. (2008) Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice. Am. J. Physiol. Heart Circ. Physiol. 295, H677-690
52. Li, D.Y., Sorensen, L.K., Brooke, B.S., Urness, L.D., Davis, E.C., Taylor, D.G., Boak, B.B., and Wendel, D.P. (1999) Defective angiogenesis in mice lacking endoglin. Science 284, 1534-1537
53. Urness, L.D., Sorensen, L.K., and Li, D.Y. (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat. Genet. 26, 328-331
54. Bourdeau, A., Dumont, D.J., and Letarte, M. (1999) A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 104, 1343-1351
55. Lehmann, K., Seemann, P., Stricker, S., Sammar, M., Meyer, B., Suring, K., Majewski, F., Tinschert, S., Grzeschik, K.H., Muller, D., Knaus, P., Nurnberg, P., and Mundlos, S. (2003) Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2. Proc. Natl Acad. Sci. USA 100, 12277-12282
56. Demirhan, O., Turkmen, S., Schwabe, G.C., Soyupak, S., Akgul, E., Tastemir, D., Karahan, D., Mundlos, S., and Lehmann, K. (2005) A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. J. Med. Genet. 42, 314-317
57. Yi, S.E., Daluiski, A., Pederson, R., Rosen, V., and Lyons, K.M. (2000) The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 127, 621-630
58. Seemann, P., Schwappacher, R., Kjaer, K.W., Krakow, D., Lehmann, K., Dawson, K., Stricker, S., Pohl, J., Ploger, F., Staub, E., Nickel, J., Sebald, W., Knaus, P., and Mundlos, S. (2005) Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J. Clin. Invest. 115, 2373-2381
59. Shore, E.M., Xu, M., Feldman, G.J., Fenstermacher, D.A., Cho, T.J., Choi, I.H., Connor, J.M., Delai, P., Glaser, D.L., LeMerrer, M., Morhart, R., Rogers, J.G., Smith, R., Triffitt, J.T., Urtizberea, J.A., Zasloff, M., Brown, M.A., and Kaplan, F.S. (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 38, 525-527
60. Fukuda, T., Kanomata, K., Nojima, J., Kokabu, S., Akita, M., Ikebuchi, K., Jimi, E., Komori, T., Maruki, Y., Matsuoka, M., Miyazono, K., Nakayama, K., Nanba, A., Tomoda, H., Okazaki, Y., Ohtake, A., Oda, H., Owan, I., Yoda, T., Haga, N., Furuya, H., and Katagiri, T. (2008) A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. Biochem. Biophys. Res. Commun. 377, 905-909
61. Yu, P.B., Deng, D.Y., Lai, C.S., Hong, C.C., Cuny, G.D., Bouxsein, M.L., Hong, D.W., McManus, P.M., Katagiri, T., Sachidanandan, C., Kamiya, N., Fukuda, T., Mishina, Y., Peterson, R.T., and Bloch, K.D. (2008) BMP type I receptor inhibition reduces heterotopic ossification. Nat. Med. 14, 1363-1369
62. Kamiya, N., Ye, L., Kobayashi, T., Mochida, Y., Yamauchi, M., Kronenberg, H.M., Feng, J.Q., and Mishina, Y. (2008) BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 135, 3801-3811
63. Hardwick, J.C., Kodach, L.L., Offerhaus, G.J., and van den Brink, G.R. (2008) Bone morphogenetic protein signalling in colorectal cancer. Nat. Rev. Cancer 8, 806-812
64. Howe, J.R., Bair, J.L., Sayed, M.G., Anderson, M.E., Mitros, F.A., Petersen, G.M., Velculescu, V.E., Traverso, G., and Vogelstein, B. (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28, 184-187
65. Beppu, H., Mwizerwa, O.N., Beppu, Y., Dattwyler, M.P., Lauwers, G.Y., Bloch, K.D., and Goldstein, A.M. (2008) Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene 27, 1063-1070
66. Liu, D., Wang, J., Kinzel, B., Müeller, M., Mao, X., Valdez, R., Liu, Y., and Li, E. (2007) Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity. Blood 110, 1502-1510
67. Yu, P.B., Hong, C.C., Sachidanandan, C., Babitt, J.L., Deng, D.Y., Hoyng, S.A., Lin, H.Y., Bloch, K.D., and Peterson, R.T. (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat. Chem. Biol. 4, 33-41
68. Wrighton, K.H., Lin, X., Yu, P.B., and Feng, X.-H. (2009) Transforming growth factor b can stimulate Smad1 phosphorylation independently of bone morphogenic protein receptors. J. Biol. Chem. 284, 9755-9763
69. Cuny, G.D., Yu, P.B., Laha, J.K., Xing, X., Liu, J.F., Lai, C.S., Deng, D.Y., Sachidanandan, C., Bloch, K.D., and Peterson, R.T. (2008) Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg. Med. Chem. Lett. 18, 4388-4392
70. Hao, J., Daleo, M.A., Murphy, C.K., Yu, P.B., Ho, J.N., Hu, J., Peterson, R.T., Hatzopoulos, A.K., and Hong, C.C. (2008) Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One 3, e2904
71. Daly, A.C., Randall, R.A., and Hill, C.S. (2008) Transforming growth factor b-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol. Cell. Biol. 28, 6889-6902
72. Liu, I.M., Schilling, S.H., Knouse, K.A., Choy, L., Derynck, R., and Wang, X.-F. (2009) TGFb-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFb switch. EMBO J. 28, 88-98
73. Murakami, M., Kawachi, H., Ogawa, K., Nishino, Y., and Funaba, M. (2009) Receptor expression modulates the specificity of transforming growth factor-b signaling pathways. Genes Cells 14, 469-482
74. Shi, Y., Hata, A., Lo, R.S., Massagué , J., and Pavletich, N.P. (1997) A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388, 87-93
75. Wu, G., Chen, Y.G., Ozdamar, B., Gyuricza, C.A., Chong, P.A., Wrana, J.L., Massagué , J., and Shi, Y. (2000) Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science 287, 92-97
76. Shi, Y., Wang, Y.F., Jayaraman, L., Yang, H., Massagué , J., and Pavletich, N.P. (1998) Crystal structure of a Smad MH1 domain bound to DNA: Insights on DNA binding in TGF-β signaling. Cell 94, 585-594
77. Shi, W., Chang, C., Nie, S., Xie, S., Wan, M., and Cao, X. (2007) Endofin acts as a Smad anchor for receptor activation in BMP signaling. J. Cell Sci. 120, 1216-1224
78. Peterson, R.S., Andhare, R.A., Rousche, K.T., Knudson, W., Wang, W., Grossfield, J.B., Thomas, R.O., Hollingsworth, R.E., and Knudson, C.B. (2004) CD44 modulates Smad1 activation in the BMP-7 signaling pathway. J. Cell Biol. 166, 1081-1091
79. Chen, Y.G. and Massagué , J. (1999) Smad1 recognition and activation by the ALK1 group of transforming growth factor-b family receptors. J. Biol. Chem. 274, 3672-3677
80. Kawabata, M., Inoue, H., Hanyu, A., Imamura, T., and Miyazono, K. (1998) Smad proteins exist as monomers in vivo and undergo homo-and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17, 4056-4065
81. Qin, B.Y., Lam, S.S., Correia, J.J., and Lin, K. (2002) Smad3 allostery links TGF-β receptor kinase activation to transcriptional control. Genes Dev. 16, 1950-1963
82. Ishida, W., Hamamoto, K., Kusanagi, K., Yagi, K., Kawabata, M., Takehara, K., Sampath, T.K., Kato, M., and Miyazono, K. (2000) Smad6 is a Smad1/5-induced Smad inhibitor: Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J. Biol. Chem. 275, 6075-6079
83. Karaulanov, E., Knochel, W., and Niehrs, C. (2004) Transcriptional regulation of BMP4 synexpression in transgenic Xenopus. EMBO J. 23, 844-856
84. Truksa, J., Lee, P., and Beutler, E. (2009) Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood 113, 688-695
85. Korchynskyi, O. and ten Dijke, P. (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277, 4883-4891
86. Ikushima, H., Komuro, A., Isogaya, K., Shinozaki, M., Hellman, U., Miyazawa, K., and Miyazono, K. (2008) An Id-like molecule, HHM, is a synexpression grouprestricted regulator of TGF-β signaling. EMBO J. 27, 2955-2965
87. Lin, X., Chen, Y.-G., and Feng, X.H. (2008) Transcriptional control via Smads in The TGF-β Family (Derynck R. and Miyazono K., eds.), pp. 287-332, Cold Spring Harbor Laboratory Press, New York
88. Ito, Y. and Miyazono, K. (2003) RUNX transcription factors as key targets of TGF-β superfamily signaling. Curr. Opin. Genet. Dev. 13, 43-47
89. Zhang, Y.-W., Yasui, N., Huang, G., Fujii, M., Hanai, J.-i., Nogami, H., Ochi, T., Miyazono, K., and Ito, Y. (2000) A RUNX2/PEBP2aA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl Acad. Sci. USA 97, 10549-10554
90. Jin, W., Takagi, T., Kanesashi, S.N., Kurahashi, T., Nomura, T., Harada, J., and Ishii, S. (2006) Schnurri- 2 controls BMP-dependent adipogenesis via interaction with Smad proteins. Dev. Cell 10, 461-471
91. Shukla, A., Malik, M., Cataisson, C., Ho, Y., Friesen, T., Suh, K.S., and Yuspa, S.H. (2009) TGF-β signalling is regulated by Schnurri-2-dependent nuclear translocation of CLIC4 and consequent stabilization of phospho-Smad2 and 3. Nat. Cell Biol. 11, 777-784
92. Jones, D.C., Wein, M.N., Oukka, M., Hofstaetter, J.G, Glimcher, M.J., and Glimcher, L.H. (2006) Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 312, 1223-1227
93. Miyazono, K., Maeda, S., and Imamura, T. (2006) Smad transcriptional co-activators and co-repressors in Smad Signal Transduction (ten Dijke P. and Heldin C.-H., eds.), pp. 277-293, Springer, The Netherlands
94. Wang, W., Mariani, F.V., Harland, R.M., and Luo, K. (2000) Ski represses bone morphogenetic protein signaling in Xenopus and mammalian cells. Proc. Natl Acad. Sci. USA 97, 14394-14399
95. Takeda, M., Mizuide, M., Oka, M., Watabe, T., Inoue, H., Suzuki, H., Fujita, T., Imamura, T., Miyazono, K., and Miyazawa, K. (2004) Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. Mol. Biol. Cell 15, 963-972
96. Alliston, T., Ko, T.C., Cao, Y., Liang, Y.Y., Feng, X.H., Chang, C., and Derynck, R. (2005) Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. J. Biol. Chem. 280, 24227-24237
97. He, W., Dorn, D.C., Erdjument-Bromage, H., Tempst, P., Moore, M.A., and Massagué , J. (2006) Hematopoiesis controlled by distinct TIF1g and Smad4 branches of the TGFb pathway. Cell 125, 929-941
98. Davis, B.N., Hilyard, A.C., Lagna, G., and Hata, A. (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56-61
99. de Jong, D.S., Vaes, B.L., Dechering, K.J., Feijen, A., Hendriks, J.M., Wehrens, R., Mummery, C.L., van Zoelen, E.J., Olijve, W., and Steegenga, W.T. (2004) Identification of novel regulators associated with early-phase osteoblast differentiation. J. Bone Miner. Res. 19, 947-958
100. Hayashi, M., Maeda, S., Aburatani, H., Kitamura, K., Miyoshi, H., Miyazono, K., and Imamura, T. (2008) Pitx2 prevents osteoblastic transdifferentiation of myoblasts by bone morphogenetic proteins. J. Biol. Chem. 283, 565-571
101. Suzuki, Y., Montagne, K., Nishihara, A., Watabe, T., and Miyazono, K. (2008) BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling. J. Biochem. 143, 199-206
102. Ota, T., Fujii, M., Sugizaki, T., Ishii, M., Miyazawa, K., Aburatani, H., and Miyazono, K. (2002) Targets of transcriptional regulation by two distinct type I receptors for transforming growth factorb in human umbilical vein endothelial cells. J. Cell. Physiol. 193, 299-318
103. Miyazono, K. and Miyazawa, K. (2002) Id: a target of BMP signaling. Sci. STKE 2002, PE40
104. Miyazono, K. (2008) Regulation of TGF-β family signaling by inhibitory Smads in The TGF-β Family (Derynck R. and Miyazono K., eds.), pp. 363-388, Cold Spring Harbor Laboratory Press, New York
105. Goto, K., Kamiya, Y., Imamura, T., Miyazono, K., and Miyazawa, K. (2007) Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors. J. Biol. Chem. 282, 20603-20611
106. Zhang, S., Fei, T., Zhang, L., Zhang, R., Chen, F., Ning, Y., Han, Y., Feng, X.H., Meng, A., and Chen, Y.G. (2007) Smad7 antagonizes transforming growth factor b signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol. Cell. Biol. 27, 4488-4499
107. Maeda, S., Hayashi, M., Komiya, S., Imamura, T., and Miyazono, K. (2004) Endogenous TGF-β signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J. 23, 552-563
108. Itoh, F., Asao, H., Sugamura, K., Heldin, C.-H., ten Dijke, P., and Itoh, S. (2001) Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J. 20, 4132-4142
109. Sapkota, G., Alarcon, C., Spagnoli, F.M., Brivanlou, A.H., and Massagué , J. (2007) Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell 25, 441-454
110. Fuentealba, L.C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda, H., Pera, E.M., and De Robertis, E.M. (2007) Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131, 980-993
111. Dupont, S., Mamidi, A., Cordenonsi, M., Montagner, M., Zacchigna, L., Adorno, M., Martello, G., Stinchfield, M.J., Soligo, S., Morsut, L., Inui, M., Moro, S., Modena, N., Argenton, F., Newfeld, S.J., and Piccolo, S. (2009) FAM/USP9x, a deubiquitinating enzyme essential for TGFb signaling, controls Smad4 monoubiquitination. Cell 136, 123-135
112. Bengtsson, L., Schwappacher, R., Roth, M., Boergermann, J.H., Hassel, S., and Knaus, P. (2009) PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1. J. Cell Sci. 122, 1248-1257
113. Yoshida, Y., Tanaka, S., Umemori, H., Minowa, O., Usui, M., Ikematsu, N., Hosoda, E., Imamura, T., Kuno, J., Yamashita, T., Miyazono, K., Noda, M., Noda, T., and Yamamoto, T. (2000) Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103, 1085-1097 (Pubitemid 32037395)
114. Chang, H., Huylebroeck, D., Verschueren, K., Guo, Q., Matzuk, M.M., and Zwijsen, A. (1999) Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 126, 1631-1642
115. Yang, X., Castilla, L.H., Xu, X., Li, C., Gotay, J., Weinstein, M., Liu, P.P., and Deng, C.X. (1999) Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 126, 1571-1580
116. Lechleider, R.J., Ryan, J.L., Garrett, L., Eng, C., Deng, C., Wynshaw-Boris, A., and Roberts, A.B. (2001) Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev. Biol. 240, 157-167
117. Tremblay, K.D., Dunn, N.R., and Robertson, E.J. (2001) Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 128, 3609-3621
118. Retting, K.N., Song, B., Yoon, B.S., and Lyons, K.M. (2009) BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 136, 1093-1104
119. Arnold, S.J., Maretto, S., Islam, A., Bikoff, E.K., and Robertson, E.J. (2006) Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. Dev. Biol. 296, 104-118
120. Hester, M., Thompson, J.C., Mills, J., Liu, Y., El-Hodiri, H.M., and Weinstein, M. (2005) Smad1 and Smad8 function similarly in mammalian central nervous system development. Mol. Cell. Biol. 25, 4683-4692
121. Huang, Z., Wang, D., Ihida-Stansbury, K., Jones, P.L., and Martin, J.F. (2009) Defective pulmonary vascular remodeling in Smad8 mutant mice. Hum. Mol. Genet. 18, 2791-2801
122. Shintani, M., Yagi, H., Nakayama, T., Saji, T., and Matsuoka, R. (2009) A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. J. Med. Genet. 46, 331-337
123. Hahn, S.A., Schutte, M., Hoque, A.T., Moskaluk, C.A., da Costa, L.T., Rozenblum, E., Weinstein, C.L., Fischer, A., Yeo, C.J., Hruban, R.H., and Kern, S.E. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353
124. Howe, J.R., Roth, S., Ringold, J.C., Summers, R.W., Järvinen, H.J., Sistonen, P., Tomlinson, I.P., Houlston, R.S., Bevan, S., Mitros, F.A., Stone, E.M., and Aaltonen, L.A. (1998) Mutations in the SMAD4/ DPC4 gene in juvenile polyposis. Science 280, 1086-1088
125. Sirard, C., de la Pompa, J.L., Elia, A., Itie, A., Mirtsos, C., Cheung, A., Hahn, S., Wakeham, A., Schwartz, L., Kern, S.E., Rossant, J., and Mak, T.W. (1998) The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12, 107-119
126. Galvin, K.M., Donovan, M.J., Lynch, C.A., Meyer, R.I., Paul, R.J., Lorenz, J.N., Fairchild- Huntress, V., Dixon, K.L., Dunmore, J.H., Gimbrone, M.A. Jr., Falb, D., and Huszar, D. (2000) A role for Smad6 in development and homeostasis of the cardiovascular system. Nat. Genet. 24, 171-174
127. Chen, Q., Chen, H., Zheng, D., Kuang, C., Fang, H., Zou, B., Zhu, W., Bu, G., Jin, T., Wang, Z., Zhang, X., Chen, J., Field, L.J., Rubart, M., Shou, W., and Chen, Y. (2009) Smad7 is required for the development and function of the heart. J. Biol. Chem. 284, 292-300
128. Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., and Matsumoto, K (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008-2011
129. Shibuya, H., Iwata, H., Masuyama, N., Gotoh, Y., Yamaguchi, K., Irie, K., Matsumoto, K., Nishida, E., and Ueno, N. (1998) Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J. 17, 1019-1028
130. Sato, S., Sanjo, H., Takeda, K., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Matsumoto, K., Takeuchi, O., and Akira, S. (2005) Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087-1095
131. Jadrich, J.L., O'Connor, M.B., and Coucouvanis, E. (2006) The TGFb activated kinase TAK1 regulates vascular development in vivo. Development 133, 1529-1541
132. Shim, J.H., Greenblatt, M.B., Xie, M., Schneider, M.D., Zou, W., Zhai, B., Gygi, S., and Glimcher, L.H. (2009) TAK1 is an essential regulator of BMP signalling in cartilage. EMBO J. 28, 2028-2041
133. Foletta, V.C., Lim, M.A., Soosairajah, J., Kelly, A.P., Stanley, E.G., Shannon, M., He, W., Das, S., Massagué , J., and Bernard, O. (2003) Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J. Cell Biol. 162, 1089-1098
134. Lee-Hoeflich, S.T., Causing, C.G., Podkowa, M., Zhao, X., Wrana, J.L., and Attisano, L. (2004) Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. EMBO J. 23, 4792-4801
135. Chan, M.C., Nguyen, P.H., Davis, B.N., Ohoka, N., Hayashi, H., Du, K., Lagna, G., and Hata, A. (2007) A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor. Mol. Cell. Biol. 27, 5776-5789
136. Koinuma, D., Tsutsumi, S., Kamimura, N., Taniguchi, H., Miyazawa, K., Sunamura, M., Imamura, T., Miyazono, K., and Aburatani, H. (2009) Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor b signaling. Mol. Cell. Biol. 29, 172-186
137. Koinuma, D., Tsutsumi, S., Kamimura, N., Imamura, T., Aburatani, H., and Miyazono, K. (2009) Promoter-wide analysis of Smad4 binding sites in human epithelial cells. Cancer Sci. 100, 2133-2142